Is DSGN undervalued or overvalued?
As of 2025-03-27, the Intrinsic Value of Design Therapeutics Inc (DSGN) is -5.97 USD. This DSGN valuation is based on the model Peter Lynch Fair Value. With the current market price of 4.15 USD, the upside of Design Therapeutics Inc is -243.89%. This means that DSGN is overvalued by 243.89%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
Range | Selected | Upside | |
a | |||
Fair Value | -5.97 - -5.97 | -5.97 | -243.89% |
DDM - Stable | (8.45) - (28.28) | (18.37) | -542.5% |
DDM - Multi | (10.10) - (26.76) | (14.73) | -454.9% |
Market Cap (mil) | 235.55 |
Beta | 2.30 |
Outstanding shares (mil) | 56.76 |
Enterprise Value (mil) | 235.55 |
Market risk premium | 4.60% |
Cost of Equity | 9.01% |
Cost of Debt | 5.00% |
WACC | 6.45% |